Abstract
Development of esophageal varices, ascites, and hepatic nephropathy is among the major complications of cirrhosis. The presence of cirrhotic cardiomyopathy, which includes a left ventricular diastolic dysfunction (DD), seems to deteriorate the course of the disease and the prognosis. Increased stiffness of the cirrhotic heart may decrease the compliance and result in DD. The prevalence of DD in cirrhotic patients averages about 50 %. It can be evaluated by transmitral Doppler echocardiography, tissue Doppler echocardiography, and cardiac magnetic resonance imaging. There seems to be a relation between DD and the severity of liver dysfunction and the presence of ascites. After liver transplantation, DD worsens the prognosis and increases the risk of graft rejection, but DD improves after few months. Insertion of a transjugular intrahepatic portosystemic shunt increases left ventricular diastolic volumes, and DD is a predictor of poorer survival in these patients. Future studies should aim at disclosing pathophysiological mechanisms behind the developing of DD in cirrhosis in relation to patient characteristics, development of complications, treatment, and risk associated with interventional procedures.
Similar content being viewed by others
Abbreviations
- AC:
-
Atrial contribution
- ANP:
-
Atrial natriuretic peptide
- BNP:
-
Brain natriuretic peptide
- BRS:
-
Baroreflex sensitivity
- CGRP:
-
Calcitonin gene-related peptide
- CMR:
-
Cardiac magnetic resonance imaging
- DD:
-
Left ventricular diastolic dysfunction
- DDT:
-
Diastolic deceleration time
- IL:
-
Interleukin
- IR:
-
Isovolumetric relaxation phase
- IVRT:
-
Isovolumetric relaxation time
- LVEF:
-
Left ventricular ejection fraction
- MELD:
-
Model of end-stage liver disease
- PICD:
-
Post-paracentesis-induced circulatory dysfunction
- RAAS:
-
Renin–angiotensin–aldosterone system
- RF:
-
Rapid filling
- SF:
-
Slow filling
- TIPS:
-
Transjugular portosystemic shunt
- TNF:
-
Tumor necrosis factor
References
Jepsen P, Vilstrup H, Andersen PK (2015) The clinical course of cirrhosis: the importance of multistate models and competing risks analysis. Hepatology 62(1):292–302
Møller S, Bendtsen F (2015) Complications of cirrhosis. A 50 years flashback. Scand J Gastroenterol 50(6):763–780
Vorobioff JD, Groszmann RJ (2015) Prevention of portal hypertension: from variceal development to clinical decompensation. Hepatology 61(1):375–381
Peck-Radosavljevic M, Angeli P, Cordoba J, Farges O, Valla D (2015) Managing complications in cirrhotic patients. United Eur Gastroenterol J 3(1):80–94
Iwakiri Y, Shah V, Rockey DC (2014) Vascular pathobiology in chronic liver disease and cirrhosis—current status and future directions. J Hepatol 61(414):912–924
Møller S, Hobolth L, Winkler C, Bendtsen F, Christensen E (2011) Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut 60:1254–1259
Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F (2015) Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol 28(1):31–40
Siniscalchi A, Aurini L, Spedicato S, Bernardi E, Zanoni A, Dante A, Cimatti M, Gamberini L, Faenza S (2013) Hyperdynamic circulation in cirrhosis: predictive factors and outcome following liver transplantation. Minerva Anestesiol 79(1):15–23
Møller S, Henriksen JH (2005) The systemic circulation in cirrhosis. In: Gines P, Arroyo V, Rodes J, Schrier RW (eds) Ascites and renal dysfunction in liver disease, 2nd edn. Blackwell, Malden, pp 139–155
Møller S, Henriksen JH, Bendtsen F (2003) Central- and non-central blood volumes in cirrhosis: relation to anthropometrics and gender. Am J Physiol Gastrointest Liver Physiol 284:G970–G979
Lenz K (2005) Hepatorenal syndrome—is it central hypovolemia, a cardiac disease, or part of gradually developing multiorgan dysfunction? Hepatology 42(2):263–265
Møller S, Bendtsen F, Henriksen JH (2006) Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume. Scand J Gastroenterol 41:451–458
Arroyo V, Fernandez J (2011) Management of hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol 7(9):517–526
Schrier RW, Masoumi A, Elhassan E (2009) Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome. Blood Purif 27(1):28–32
Wiese S, Hove JD, Bendtsen F, Møller S (2014) Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 11(3):177–186
Karagiannakis DS, Papatheodoridis G, Vlachogiannakos J (2015) Recent advances in cirrhotic cardiomyopathy. Dig Dis Sci 60(5):1141–1151
Zardi EM, Zardi DM, Chin D, Sonnino C, Dobrina A, Abbate A (2015) Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase. J Cardiol 15:10
Møller S, Henriksen JH (2010) Cirrhotic cardiomyopathy. J Hepatol 53(1):179–190
Gaskari SA, Honar H, Lee SS (2006) Therapy insight: cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol 3(6):329–337
Glenn TK, Honar H, Liu H, ter Keurs HE, Lee SS (2011) Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats. J Hepatol 55(6):1249–1255
Saner FH, Neumann T, Canbay A, Treckmann JW, Hartmann M, Goerlinger K, Bertram S, Beckebaum S, Cicinnati V, Paul A (2011) High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int 24:425–432
Møller S, Bernardi M (2013) Interactions of the heart and the liver. Eur Heart J 34:2804–2811
Arroyo V, Colmenero J (2003) Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 38(Suppl 1):S69–S89
Møller S, Bendtsen F, Henriksen JH (2001) Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand J Clin Lab Invest 61(6):421–429
Buck M, Garcia-Tsao G, Groszmann RJ, Stalling C, Grace ND, Burroughs AK, Patch D, Matloff DS, Clopton P, Chojkier M (2014) Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients. Hepatology 59(3):1052–1059
Schrier RW (2007) Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 18(7):2028–2031
Licata A, Novo G, Colomba D, Tuttolomondo A, Galia M, Camma’ C (2016) Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis. J Cardiovasc Med (Hagerstown) 17(1):26–36
Brinch K, Møller S, Bendtsen F, Becker U, Henriksen JH (2003) Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 39(1):24–31
Kiszka-Kanowitz M, Henriksen JH, Møller S, Bendtsen F (2001) Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol 35(5):605–612
Ruiz-Del-Arbol L, Monescillo A, Arocena C, Valer P, Gines P, Moreira V, Maria MJ, Jimenez W, Arroyo V (2005) Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42:439–447
Krag A, Bendtsen F, Henriksen JH, Møller S (2010) Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 59(1):105–110
Krag A, Møller S, Burroughs AK, Bendtsen F (2012) Betablockers induce cardiac chronotropic incompetence. J Hepatol 56(1):298–299
Tripathi D, Hayes PC (2014) Beta-blockers in portal hypertension: new developments and controversies. Liver Int 34(5):655–667
Alqahtani SA, Fouad TR, Lee SS (2008) Cirrhotic cardiomyopathy. Semin Liver Dis 28(1):59–69
Møller S, Henriksen JH (2008) Cardiovascular complications of cirrhosis. Gut 57(2):268–278
Wong F (2009) Cirrhotic cardiomyopathy. Hepatol Int 3(1):294–304
Zambruni A, Di Micoli A, Lubisco A, Domenicali M, Trevisani F, Bernardi M (2007) QT interval correction in patients with cirrhosis. J Cardiovasc Electrophysiol 18(1):77–82
Trevisani F, Di Micoli A, Zambruni A, Biselli M, Santi V, Erroi V, Lenzi B, Caraceni P, Domenicali M, Cavazza M, Bernardi M (2012) QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver Int 32(10):1510–1515
Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L (2001) The cardiac response to exercise in cirrhosis. Gut 49(2):268–275
Krag A, Bendtsen F, Mortensen C, Henriksen JH, Møller S (2010) Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis. Eur J Gastroenterol Hepatol 22(9):1085–1092
Kazankov K, Holland-Fischer P, Andersen NH, Torp P, Sloth E, Aagaard NK, Vilstrup H (2011) Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int 31(4):534–540
Sampaio F, Pimenta J, Bettencourt N, Fontes-Carvalho R, Silva AP, Valente J, Bettencourt P, Fraga J, Gama V (2013) Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study. Liver Int 33(8):1158–1165
Pozzi M, Redaelli E, Ratti L, Poli G, Guidi C, Milanese M, Calchera I, Mancia G (2005) Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterol Dietol 51(2):179–186
Krag A, Bendtsen F, Burroughs AK, Møller S (2012) The cardiorenal link in advanced cirrhosis. Med Hypotheses 79(1):53–55
Møller S, Bendtsen F (2015) Cirrhotic multiorgan syndrome. Dig Dis Sci 60(11):3209–3225
Opie LH (1998) The heart: physiology, from cell to circulation, 3rd edn. Lippincott, Philadelphia
Palmiero P, Zito A, Maiello M, Cameli M, Modesti PA, Muiesan ML, Novo S, Saba PS, Scicchitano P, Pedrinelli R, Ciccone MM (2015) Left ventricular diastolic function in hypertension: methodological considerations and clinical implications. J Clin Med Res 7(3):137–144
Ganong WF (1993) Review of medical physiology, 16th edn. Lange, Los Altos
Shapiro BP, Lam CS, Patel JB, Mohammed SF, Kruger M, Meyer DM, Linke WA, Redfield MM (2007) Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model. Hypertension 50(3):503–511
Ouzounian M, Lee DS, Liu PP (2008) Diastolic heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med 5(7):375–386
Henriksen JH, Bendtsen F, Moller S (2015) Acid-base disturbance in patients with cirrhosis: relation to hemodynamic dysfunction. Eur J Gastroenterol Hepatol 27(8):920–927
Groszmann RJ (1997) Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly. Gastroenterology 113:1794–1797
Møller S, Krag A, Madsen JL, Henriksen JH, Bendtsen F (2009) Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension. Liver Int 29:1528–1537
Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, Meregaglia D, Nicolini A (2007) Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut 56(6):869–875
Dowsley TF, Bayne DB, Langnas AN, Dumitru I, Windle JR, Porter TR, Raichlin E (2012) Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation 94(6):646–651
Fili D, Falletta C, Luca A, Hernandez BC, Clemenza F, Miraglia R, Scardulla C, Tuzzolino F, Vizzini G, Gridelli B, Bosch J (2015) Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: relationship with diastolic dysfunction. Dig Liver Dis 15:10
Daneshvar D, Wei J, Tolstrup K, Thomson LE, Shufelt C, Merz CN (2010) Diastolic dysfunction: improved understanding using emerging imaging techniques. Am Heart J 160(3):394–404
Ruiz-Del-Arbol L, Achecar L, Serradilla R, Rodriguez-Gandia MA, Rivero M, Garrido E, Natcher JJ (2013) Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension and a normal creatinine. Hepatology 58(5):1732–1742
Dokainish H (2015) Left ventricular diastolic function and dysfunction: central role of echocardiography. Glob Cardiol Sci Pract 2015:3. doi:10.5339/gcsp.2015.3.eCollection;%2015.:3
Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kuhl U, Schultheiss HP, Tschope C (2011) Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol 57(8):977–985
Solomon SD, Wu J, Gillam L (2015) Echocardiography. In: Mann DL, Zipes D, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease: a textbook of cardiovascular medicine, 10th edn. Elsevier, Philadelphia, pp 179–260
Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10(2):165–193
Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschope C (2007) Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 116(6):637–647
Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102(15):1788–1794
Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, Mcmurray JJ, Solomon SD (2014) Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 63(5):447–456
Kasner M, Gaub R, Sinning D, Westermann D, Steendijk P, Hoffmann W, Schultheiss HP, Tschope C (2010) Global strain rate imaging for the estimation of diastolic function in HFNEF compared with pressure-volume loop analysis. Eur J Echocardiogr 11(9):743–751
Di SG, Caso P, Lo PR, Fusco A, Martiniello AR, Russo MG, D’Onofrio A, Severino S, Calabro P, Pacileo G, Mininni N, Calabro R (2005) Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 112(3):387–395
Inaba Y, Yuda S, Kobayashi N, Hashimoto A, Uno K, Nakata T, Tsuchihashi K, Miura T, Ura N, Shimamoto K (2005) Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 18(7):729–736
Kurt M, Wang J, Torre-Amione G, Nagueh SF (2009) Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging 2(1):10–15
Lawton JS, Cupps BP, Knutsen AK, Ma N, Brady BD, Reynolds LM, Pasque MK (2011) Magnetic resonance imaging detects significant sex differences in human myocardial strain. Biomed Eng Online 10(76):76
Zagrosek A, Abdel-Aty H, Boye P, Wassmuth R, Messroghli D, Utz W, Rudolph A, Bohl S, Dietz R, Schulz-Menger J (2009) Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2(2):131–138
Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52(19):1574–1580
Kasner M, Westermann D, Schultheiss HP, Tschope C (2012) Diastolic heart failure and LV dyssynchrony. Curr Pharm Biotechnol 13(13):2539–2544
Wong F, Villamil A, Merli M, Romero G, Angeli P, Caraceni P, Steib CJ, Baik SK, Spinzi G, Colombato LA, Salerno F (2011) Prevalence of diastolic dysfunction in cirrhosis and its clinical significance. Hepatology 54:475A (Abstract)
Carvalheiro F, Rodrigues C, Adrego T, Viana J, Vieira H, Seco C, Pereira L, Pinto F, Eufrasio A, Bento C, Furtado E (2016) Diastolic dysfunction in liver cirrhosis: prognostic predictor in liver transplantation? Transplant Proc 48(1):128–131
Wiese S, Mortensen C, Gotze JP, Christensen E, Andersen O, Bendtsen F, Møller S (2014) Cardiac and proinflammatory markers predict prognosis in cirrhosis. Liver Int 34(6):e19–e30
Papastergiou V, Skorda L, Lisgos P, Papakonstantinou N, Giakoumakis T, Ntousikos K, Karatapanis S (2012) Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: is there a correlation between the grade of diastolic dysfunction and the grade of liver disease? Sci World J 2012:615057
Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD (2013) Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci 58(10):3029–3036
Salari A, Shafaghi A, Ofoghi M, Saeidinia A, Mansour-Ghanaei F (2013) Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients. Int J Hepatol 2013:892876. doi:10.1155/2013/892876
Merli M, Calicchia A, Ruffa A, Pellicori P, Riggio O, Giusto M, Gaudio C, Torromeo C (2013) Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med 24(2):172–176
Nazar A, Guevara M, Sitges M, Terra C, Sola E, Guigou C, Arroyo V, Gines P (2013) Left ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol 58(1):51–57
De BK, Majumdar D, Das D, Biswas PK, Mandal SK, Ray S, Bandopadhyay K, Das TK, Dasgupta S, Guru S (2003) Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis. J Hepatol 39(3):315–319
Dahl EK, Møller S, Kjaer A, Petersen CL, Bendtsen F, Krag A (2014) Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study. Scand J Gastroenterol 49:362–372
Raizada V, Skipper B, Luo W, Griffith J (2007) Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects. J Investig Med 55(7):341–359
Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, De Castro S, Merli M (2000) Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 95(11):3200–3205
Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB, Roffi L, Failla M, Grassi G, Giannattasio C, Mancia G (1997) Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 26(5):1131–1137
Dadhich S, Goswami A, Jain VK, Gahlot A, Kulamarva G, Bhargava N (2014) Cardiac dysfunction in cirrhotic portal hypertension with or without ascites. Ann Gastroenterol 27(3):244–249
Gines P, Angeli P, Lenz K, Møller S, Moore K, Moreau R, Merkel C, Ring-Larsen H, Bernardi M, Garcia-Tsao G, Hayes P (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53(3):397–417
Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS (2010) Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int 30(7):937–947
Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R (2013) Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. doi:10.1002/hep.26338.:10
Nasr G, Hassan A, Ahmed S, Serwah A (2010) Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites. J Cardiovasc Dis Res 1(3):136–144
Umgelter A, Reindl W, Wagner KS, Franzen M, Stock K, Schmid RM, Huber W (2008) Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial. Crit Care 12(1):R4
Schneditz D, Bachler I, Stadlbauer V, Stauber RE (2008) Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements. Int J Clin Pract 62(12):1851–1857
Karagiannakis D, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas S (2014) Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis. Hepatol Int 8(4):588–594
Rabie RN, Cazzaniga M, Salerno F, Wong F (2009) The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 104:2458–2466
Alexopoulou A, Papatheodoridis G, Pouriki S, Chrysohoou C, Raftopoulos L, Stefanadis C, Pectasides D (2012) Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transpl Int 25(11):1174–1181
Sampaio F, Pimenta J, Bettencourt N, Fontes-Carvalho R, Silva AP, Valente J, Bettencourt P, Fraga J, Gama V (2014) Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis. Eur J Intern Med 25(241):246
Holt EW, Woo G, Trilesskaya M, Haeusslein EA, Shaw RE, Frederick RT (2011) Diastolic dysfunction defined by E/A ratio < 1 on 2-D echo is an independent predictor of liver transplantation or death in patient with cirrhosis. J Hepatol 54(Suppl 1):245–246 (Abstract)
Piscaglia F, Zironi G, Gaiani S, Mazziotti A, Cavallari A, Gramantieri L, Valgimigli M, Bolondi L (1999) Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Hepatology 30(1):58–64
Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS (2003) Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 37(2):393–400
Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC (2002) Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl 8(8):690–700
Torregrosa M, Aguade S, Dos L, Segura R, Gonzalez A, Evangelista A, Castell J, Margarit C, Esteban R, Guardia J, Genesca J (2005) Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 42(1):68–74
Mittal C, Qureshi W, Singla S, Ahmad U, Huang MA (2014) Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure. Dig Dis Sci 59(3):674–680
Raevens S, De Pauw M, Geerts A, Berrevoet F, Rogiers X, Troisi RI, Van Vlierberghe H, Colle I (2014) Prevalence and outcome of diastolic dysfunction in liver transplantation recipients. Acta Cardiol 69(3):273–280
Ripoll C, Yotti R, Bermejo J, Banares R (2010) The heart in liver transplantation. J Hepatol 54:810–822
Busk TM, Bendtsen F, Møller S (2013) Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol 25(5):523–530
Rössle M, Gerbes AL (2010) TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 59(7):988–1000
Møller S, Hove JD, Dixen U, Bendtsen F (2013) New insights into cirrhotic cardiomyopathy. Int J Cardiol 167:1101–1108
Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rôssle M (1999) Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 44(5):743–748
Merli M, Valeriano V, Funaro S, Attili AF, Masini A, Efrati C, De CS, Riggio O (2002) Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 97(1):142–148
Kovacs A, Schepke M, Heller J, Schild HH, Flacke S (2009) Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results. Cardiovasc Interv Radiol 33:290–296
Acknowledgments
SM received a research grant from the Novo Nordisk Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Møller, S., Wiese, S., Halgreen, H. et al. Diastolic dysfunction in cirrhosis. Heart Fail Rev 21, 599–610 (2016). https://doi.org/10.1007/s10741-016-9552-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-016-9552-9